In Poland, health care and devices market gains momentum

29 January 2007

Treatment patterns, the provision of health care and availability of funding have been influenced by the accession of Poland into the European Union. Poland represents a growing market for medical devices and other health care industries and is now the most preferred choice for manufacturers looking to expand operations into the newly emerging health care markets of Europe.

Based on published sources, Frost & Sullivan estimates that the size of the medical device market in Poland was $1,290.0 million in 2005.

Accession into the EU has proven to be highly beneficial in financial terms, with fund transfers from the EU poised to generate additional capital flows into Poland. In 2004, foreign direct investments into the country stood at nearly $7.9 billion, marking an increase of almost 23% from 2003. This also represented the highest increase of FDI into Poland over the last four years.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight